Case Study submissions should focus on the use of HEOR to inform a healthcare decision or series of decisions, noting successes and lessons learned. The scope of case studies could be local (for example, from a local healthcare payer or provider organization serving a small jurisdiction or region) to national (for example, from a regulator or HTA body serving a country). Case studies should be presented from defined stakeholder perspective(s) such as payer, patient, provider, industry, or government (including government-affiliated or government-commissioned organizations). Academic entities whose research informs healthcare decisions are also encouraged to submit their work.

An important distinction between Case Studies and Research submission categories is that Case Studies employ the following format and may include qualitative descriptions of experiences without necessarily involving formal research design or execution.

SUBMISSION INFORMATION

ISPOR is strongly committed to diversity. The Society’s Strategic Plan and core values embrace excellence through encouragement and acceptance of diverse ideas, cultures, and disciplines. Case study submissions are encouraged from all stakeholders and are evaluated based on merit. ISPOR also aims to reflect the diversity of its membership in all endeavors and encourages consideration of diversity in abstract submissions. Diversity dimensions include (but not limited to) gender, career stage, ethnicity, race, education, sexual orientation, region/geographic location, physical disability, and religion. Additional information can be found at the Society’s Diversity Policy.

  • All topics are welcome, but we also encourage the submission around the topic of real-world evidence.
  • Abstracts that have been submitted to another conference and copyright has been transferred to another organization will not be considered.
  • Case study abstracts presented at a previous ISPOR meeting are not allowed.
  • Accepted case studies are presented as an oral presentation. Total case study presentation time will be 15-20 minutes, depending on the number of presenters. Accepted case studies may be grouped with 2 or more abstracts in a session.
  • Example of a case study abstract submission is available here.
  • Length of Abstract: 300 words

SUBMISSION INSTRUCTIONS

Below are instructions to assist with your case study abstract submission. If you have any questions concerning the research submission process, please contact conferences@ispor.org. 

STEP 1: TITLE
When submitting your abstract, titles must be submitted in title case. Titles have a 225 maximum character limit. Your title should succinctly state the topic of the work.

STEP 2 & 3: MAIN TOPIC/TAXONOMY AND SUBTOPICS FOR RESEARCH SUBMISSIONS
When submitting your abstract, you must select at least one topic and subtopic that best describes your abstract. This topic/taxonomy will also be used to assign the appropriate peer reviewer to your submission.

After selecting your main topic/taxonomy, you may then choose up to four subtopics. Expand each taxonomy area below to view the available subcategories. If these subtopic areas do not apply to your research, select “Does Not Apply” at the bottom of the “Subtopics” page.

Clinical Outcomes

Comparative Effectiveness or Efficacy

Performance-based Outcomes

Clinician Reported Outcomes

Clinician Outcomes Assessment

Relating Intermediate to Long-term Outcomes

Economic Evaluation

Cost/Cost of Illness/Resource Use Studies

Cost-comparison/effectiveness/utility/benefit Analysis

Budget Impact Analysis

Thresholds & Opportunity Cost

Trial-based economic evaluation

Work & Home Productivity - Indirect Costs

Value of Information

Novel & Social Elements of Value

Epidemiology & Public Health

Safety & Pharmacoepidemiology

Public Health

Prevalence, Incidence, & Disease Risk Factors

Disease Classification & Coding

 

Health Policy & Regulatory

Approval & Labeling

Pricing Policy & Schemes

Reimbursement & Access Policy

Insurance Systems & National Health Care

Public Spending & National Health Expenditures

Procurement Systems

Coverage with Evidence Development & Adaptive Pathways

Risk-sharing Approaches

Health Disparities & Equity

 

Health Service Delivery & Process of Care

Hospital and Clinical Practices

Prescribing Behavior

Pharmacist Interventions and Practices

Formulary Development

Telemedicine

Quality of Care Measurement

Disease Management (including optimization studies)

Treatment Patterns and Guidelines

Health Technology Assessment

Systems & Structure

Value Frameworks & Dossier Format

Decision & Deliberative Processes

 

Medical Technologies

Medical Devices

Digital Health (includes HIT, mhealth, wearables)

Diagnostics & Imaging

Implementation Science

 

Methodological & Statistical Research

Artificial Intelligence, Machine Learning, Predictive Analytics

Missing Data

Confounding, Selection Bias Correction, Causal Inference

Modeling & Simulation

PRO & Related Methods

Survey Methods

 

Organizational Practices

Academic & Educational

Industry

Ethical

Best Research Practices

Geographic & Regional (not for epidemiology or treatment evaluation studies of population subgroups)

 

Patient-Centered Research

Adherence, Persistence, & Compliance

Stated Preference & Patient Satisfaction

Health State Utilities

Patient-reported Outcomes & Quality of Life Outcomes

Patient Behavior and Incentives

Patient Engagement

Instrument Development, Validation, & Translation

 

Real World Data & Information Systems

Data Protection, Integrity, & Quality Assurance

Health & Insurance Records Systems

Distributed Data & Research Networks

Reproducibility & Replicability

 

Study Approaches

Administrative Claims Data

Clinical Trials

Decision Modeling & Simulation

Electronic Medical & Health Records

Literature Review & Synthesis

Meta-analysis & Indirect Comparisons

Pragmatic Trials & Large Simple Trials

Prospective Observational Studies

Registries

Surveys & Expert Panels

STEP 4: PRIMARY SPECIFIC DISEASE & CONDITIONS/SPECIALIZED TREATMENT AREAS FOR CASE STUDY SUBMISSIONS
Accepted case study abstracts are grouped according to specific diseases/specialized treatment areas for panel presentations. Please indicate one specific diseases/specialized treatment areas below to assist in assigning your abstract for poster presentation. You can select "No Specific Disease" if these choices do not apply.

Please note you will have the opportunity to select additional specific diseases/specialized treatment areas to represent your research on the next submission step.

Specific Diseases & Conditions

Cardiovascular Disorders (including MI, Stroke, Circulatory)

Diabetes/Endocrine/Metabolic Disorders (including obesity)

Gastrointestinal Disorders      

Geriatrics

Infectious Disease (non-vaccine)

Injury & Trauma

Mental Health (including addition)                 

Musculoskeletal Disorders (Arthritis, Bone Disorders, Osteoporosis, Other Musculoskeletal) 

Neurological Disorders

Oncology

Pediatrics

Rare & Orphan Diseases

Reproductive & Sexual Health

Respiratory-Related Disorders (Allergy, Asthma, Smoking, Other Respiratory)              

Sensory System Disorders (Ear, Eye, Dental, Skin)  

Systemic Disorders/Conditions (Anesthesia, Auto-Immune Disorders (n.e.c.), Hematological Disorders (non-oncologic), Pain)  

Urinary/Kidney Disorders

 

Specialized Treatment Areas

Alternative Medicine

Biologics & Biosimilars

Drugs

Genetic, Regenerative & Curative Therapies

Generics

Medical Devices

Nutrition

Personalized & Precision Medicine

Surgery

Vaccines

Veterinary Medicine

 

 

STEP 5: SPECIFIC DISEASE/SPECIALIZED TREATMENT AREAS FOR CASE STUDY SUBMISSIONS
In addition to your primary disease provided on the previous page, please select up to four additional disease & conditions/specialized treatment areas that best describe your abstract.

If you do not want to select any additional options, select "No Additional Disease & Conditions/Specialized Treatment Areas."

STEP 6: LOCATION TAXONOMY
Select all geographic regions that apply to your case study abstract.

STEP 7: AUTHORS
Include all authors that are affiliated with your case study abstract. You will have to assign at least one Presenting Author upon submission. No more than 3 authors can be designated as a presenter. If multiple perspectives are being included, then coauthors/presenters representing each perspective are expected. Total case study presentation time will be 15-20 minutes, depending on the number of presenters. Please note: you will have the opportunity to update your presenting author(s) closer to the conference. 

All accepted presenting authors must register for the meeting and are responsible for their meeting registration fees, unless otherwise notified in writing by ISPOR. 

Submitters will receive confirmation of submission. It is the responsibility of the submitter to coordinate with authors after the submission status notification is received. ISPOR will communicate then with presenting authors directly regarding their abstract’s acceptance/rejection status and conference participation. 

STEP 8: ABSTRACT TEXT 
Copy and paste your abstract text from your preferred Word processor. Do not remove included headers (Problem Statement, Description, Lessons Learned, Stakeholder Perspective). Abstract has a 300 maximum word count. You can apply special formatting using the provided buttons along the top of the text box.

STEP 9: CONFIRMATION
Review your submission and complete the “Final Steps” acknowledgement form at the bottom. You must complete this final step and select “Conclude Submission,” otherwise your submission will be considered incomplete and not submitted for review. Please note: you will need to complete this step every time you update your submission.


CRITERIA FOR EVALUATION OF CASE STUDY ABSTRACTS:

Please consider the updated submission criteria when submitting your proposal:

Quality of content

  • Educational value of the session
  • Timeliness of the topic
  • Applicability of content to HEOR practice or principles
  • Unbiased content that does not promote a product, service, or organization; (abstracts deemed to be promotional will be excluded from consideration)

How well does the submission meet the topic it was submitted under?

Was there a lesson learned?

Are multiple stakeholders/organizations represented?

How well does the submission clearly identify the issue or problem being addressed?

How well does the submission exemplify the use of HEOR in healthcare decision-making?

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×